Monthly
US$200
Billed every month
Sign in to subscribeAs of 13 November 2026, for Diclofenac Sodium Sustained Release Tablets, 10 applications are listed as under review at China's CDE; 3 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 14 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 4 applications
Current coverage may be incomplete
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Loaded records: 14 holders; 5 in the quality-and-efficacy consistency-evaluation category, and 9 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Hefei He Yuan Pharma Co., Ltd. romanized | Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20265435 | 2026/07/28 | 100mg | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264648 | 2026/06/03 | 100mg | Generic approved under the new chemical-drug registration classification | CDE |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 2026/06/02 | 0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | 国药准字H20264430 | 2026/05/19 | 100mg | Generic approved under the new chemical-drug registration classification | CDE |
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | 国药准字H20264471 | 2026/05/19 | 75mg | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 2026/03/03 | 100mg | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Di Er Pharma Co., Ltd. romanized | Zhejiang Di Er Pharma Co., Ltd. romanized | 国药准字H20083921 | 2025/10/31 | 0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20255690 | 2025/10/14 | 75mg | Generic approved under the new chemical-drug registration classification | CDE |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20255691 | 2025/10/14 | 100mg | Generic approved under the new chemical-drug registration classification | CDE |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20254097 | 2025/05/13 | 100mg | Generic approved under the new chemical-drug registration classification | CDE |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20254096 | 2025/05/13 | 75mg | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 2024/08/27 | 75mg | Generic approved under the new chemical-drug registration classification | CDE |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20067776 | 2023/12/18 | 0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20010604 | 2023/09/15 | 0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 2023/06/27 | 100mg | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 2023/06/27 | 75mg | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Yi Heng Pharmaceutical Co., Ltd. romanized | Nanjing Yi Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20213301 | 2021/04/27 | 100mg | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Yi Heng Pharmaceutical Co., Ltd. romanized | Nanjing Yi Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20213300 | 2021/04/27 | 75mg | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H10970209 | 2020/01/07 | 0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hefei He Yuan Pharma Co., Ltd. romanized | Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20265436 | 2026/07/28 | 75mg | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
Loaded records: 24 distinct approval numbers and 18 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Zhong Mei Tianjin Shi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H10980297 | 75mg | Category A | XM01ABS120A010010100100 | NHSA |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 75mg | Category A | XM01ABS120A010010100465 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H10970209 | 0.1g | Category A | XM01ABS120A010010100555 | NHSA |
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | 国药准字H20264430 | 100mg | Category A | XM01ABS120A010010100601 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20010604 | 0.1g | Category A | XM01ABS120A010010100818 | NHSA |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20254096 | 75mg | Category A | XM01ABS120A010010101190 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010010101206 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264648 | 100mg | Category A | XM01ABS120A010010101503 | NHSA |
| Nanjing Yi Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20213300 | 75mg | Category A | XM01ABS120A010010101605 | NHSA |
| Sichuan Hua Xin Pharmaceutical Co., Ltd. romanized | 国药准字H19991402 | 0.1g | Category A | XM01ABS120A010010102160 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010010102251 | NHSA |
| De Zhou De Yao Pharmaceutical Co., Ltd. romanized | 国药准字H10970008 | 0.1g | Category A | XM01ABS120A010010103942 | NHSA |
| Zhejiang Di Er Pharma Co., Ltd. romanized | 国药准字H20083921 | 0.1g | Category A | XM01ABS120A010010104623 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20255690 | 75mg | Category A | XM01ABS120A010010104658 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20067776 | 0.1g | Category A | XM01ABS120A010010104929 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010010109531 | NHSA |
| Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20265436 | 75mg | Category A | XM01ABS120A010010109541 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010010182922 | NHSA |
| Zhong Mei Tianjin Shi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H10980297 | 75mg | Category A | XM01ABS120A010010200100 | NHSA |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 75mg | Category A | XM01ABS120A010010200465 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H10970209 | 0.1g | Category A | XM01ABS120A010010200555 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20010604 | 0.1g | Category A | XM01ABS120A010010200818 | NHSA |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20254096 | 75mg | Category A | XM01ABS120A010010201190 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010010201206 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264648 | 100mg | Category A | XM01ABS120A010010201503 | NHSA |
| Sichuan Hua Xin Pharmaceutical Co., Ltd. romanized | 国药准字H19991402 | 0.1g | Category A | XM01ABS120A010010202160 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010010202251 | NHSA |
| De Zhou De Yao Pharmaceutical Co., Ltd. romanized | 国药准字H10970008 | 0.1g | Category A | XM01ABS120A010010203942 | NHSA |
| Zhejiang Di Er Pharma Co., Ltd. romanized | 国药准字H20083921 | 0.1g | Category A | XM01ABS120A010010204623 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20255690 | 75mg | Category A | XM01ABS120A010010204658 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20067776 | 0.1g | Category A | XM01ABS120A010010204929 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010010209531 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010010282922 | NHSA |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 75mg | Category A | XM01ABS120A010010300465 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H10970209 | 0.1g | Category A | XM01ABS120A010010300555 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20010604 | 0.1g | Category A | XM01ABS120A010010300818 | NHSA |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20254096 | 75mg | Category A | XM01ABS120A010010301190 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010010301206 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264648 | 100mg | Category A | XM01ABS120A010010301503 | NHSA |
| Sichuan Hua Xin Pharmaceutical Co., Ltd. romanized | 国药准字H19991402 | 0.1g | Category A | XM01ABS120A010010302160 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010010302251 | NHSA |
| De Zhou De Yao Pharmaceutical Co., Ltd. romanized | 国药准字H10970008 | 0.1g | Category A | XM01ABS120A010010303942 | NHSA |
| Zhejiang Di Er Pharma Co., Ltd. romanized | 国药准字H20083921 | 0.1g | Category A | XM01ABS120A010010304623 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20255690 | 75mg | Category A | XM01ABS120A010010304658 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20067776 | 0.1g | Category A | XM01ABS120A010010304929 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010010382922 | NHSA |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 75mg | Category A | XM01ABS120A010010400465 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H10970209 | 0.1g | Category A | XM01ABS120A010010400555 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20010604 | 0.1g | Category A | XM01ABS120A010010400818 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010010401206 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264648 | 100mg | Category A | XM01ABS120A010010401503 | NHSA |
| Sichuan Hua Xin Pharmaceutical Co., Ltd. romanized | 国药准字H19991402 | 0.1g | Category A | XM01ABS120A010010402160 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010010402251 | NHSA |
| Zhejiang Di Er Pharma Co., Ltd. romanized | 国药准字H20083921 | 0.1g | Category A | XM01ABS120A010010404623 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20255690 | 75mg | Category A | XM01ABS120A010010404658 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20067776 | 0.1g | Category A | XM01ABS120A010010404929 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010010482922 | NHSA |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 75mg | Category A | XM01ABS120A010010500465 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H10970209 | 0.1g | Category A | XM01ABS120A010010500555 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010010501206 | NHSA |
| Sichuan Hua Xin Pharmaceutical Co., Ltd. romanized | 国药准字H19991402 | 0.1g | Category A | XM01ABS120A010010502160 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010010502251 | NHSA |
| Zhejiang Di Er Pharma Co., Ltd. romanized | 国药准字H20083921 | 0.1g | Category A | XM01ABS120A010010504623 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20067776 | 0.1g | Category A | XM01ABS120A010010504929 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010010582922 | NHSA |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 75mg | Category A | XM01ABS120A010010600465 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H10970209 | 0.1g | Category A | XM01ABS120A010010600555 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010010601206 | NHSA |
| Sichuan Hua Xin Pharmaceutical Co., Ltd. romanized | 国药准字H19991402 | 0.1g | Category A | XM01ABS120A010010602160 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010010602251 | NHSA |
| Zhejiang Di Er Pharma Co., Ltd. romanized | 国药准字H20083921 | 0.1g | Category A | XM01ABS120A010010604623 | NHSA |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | 国药准字H20067776 | 0.1g | Category A | XM01ABS120A010010604929 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010010682922 | NHSA |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 75mg | Category A | XM01ABS120A010010700465 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010010701206 | NHSA |
| Sichuan Hua Xin Pharmaceutical Co., Ltd. romanized | 国药准字H19991402 | 0.1g | Category A | XM01ABS120A010010702160 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010010702251 | NHSA |
| Zhejiang Di Er Pharma Co., Ltd. romanized | 国药准字H20083921 | 0.1g | Category A | XM01ABS120A010010704623 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010010782922 | NHSA |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 75mg | Category A | XM01ABS120A010010800465 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010010801206 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010010802251 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010010882922 | NHSA |
| Guangdong Xiang Shan Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20244747 | 75mg | Category A | XM01ABS120A010010900465 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010010901206 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010010902251 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010010982922 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010011002251 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233809 | 75mg | Category A | XM01ABS120A010011082922 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010011101206 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010011102251 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010011201206 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010011202251 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010011301206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010011401206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010011501206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010011601206 | NHSA |
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | 国药准字H20264471 | 75mg | Category A | XM01ABS120A010020100601 | NHSA |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20254097 | 100mg | Category A | XM01ABS120A010020101190 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010020101206 | NHSA |
| Nanjing Yi Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20213301 | 100mg | Category A | XM01ABS120A010020101605 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20255691 | 100mg | Category A | XM01ABS120A010020104658 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010020109531 | NHSA |
| Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20265435 | 100mg | Category A | XM01ABS120A010020109541 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010020182922 | NHSA |
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | 国药准字H20264471 | 75mg | Category A | XM01ABS120A010020200601 | NHSA |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20254097 | 100mg | Category A | XM01ABS120A010020201190 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20255691 | 100mg | Category A | XM01ABS120A010020204658 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010020209531 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010020282922 | NHSA |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20254097 | 100mg | Category A | XM01ABS120A010020301190 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20255691 | 100mg | Category A | XM01ABS120A010020304658 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010020309531 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010020382922 | NHSA |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20254097 | 100mg | Category A | XM01ABS120A010020401190 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010020409531 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010020482922 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010020509531 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010020582922 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010020609531 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010020682922 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010020709531 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010020782922 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010020809531 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010020882922 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010020909531 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010020982922 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20233810 | 100mg | Category A | XM01ABS120A010021082922 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010021701206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010021801206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010021901206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010022001206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010022101206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010022201206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010022301206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010022401206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010022501206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010022601206 | NHSA |
| Liaoning Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20194038 | 0.1g | Category A | XM01ABS120A010022701206 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010030109531 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010030209531 | NHSA |
| Ya Bao Pharma Group Co., Ltd. romanized | 国药准字H20103737 | See source | Category A | XM01ABS120A010030309531 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20263511 | 100mg | Category A | XM01ABS120A010011302251 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Loaded records: 10 filings and 7 distinct first applicants.
Supplement 2 · Generic 8
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | CYHB2601687 | Supplement | 2026/09/04 | Not stated by source | CDE |
| Jin Yao Da Ren Tang Group Co., Ltd. Xin Xin Pharmaceutical Factory romanized | CYHB2601639 | Supplement | 2026/08/26 | Not stated by source | CDE |
| Tianjin Mei Hua Biopharmaceuticals Technology Co., Ltd. romanized | CYHS2602079 | Generic | 2026/08/20 | Not stated by source | CDE |
| Tianjin Mei Hua Biopharmaceuticals Technology Co., Ltd. romanized | CYHS2602078 | Generic | 2026/08/20 | Not stated by source | CDE |
| Hunan Zhuang Yuan Pharmaceutical Co., Ltd. romanized; HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2600541 | Generic | 2026/02/26 | Not stated by source | CDE |
| Hunan Zhuang Yuan Pharmaceutical Co., Ltd. romanized; HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2600540 | Generic | 2026/02/26 | Not stated by source | CDE |
| Guo Yuan Guo Yao (Guangdong) Pharmaceutical Group Co., Ltd. romanized | CYHS2600016 | Generic | 2026/01/05 | Not stated by source | CDE |
| Guo Yuan Guo Yao (Guangdong) Pharmaceutical Group Co., Ltd. romanized | CYHS2600015 | Generic | 2026/01/05 | Not stated by source | CDE |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | CYHS2503698 | Generic | 2025/10/16 | Not stated by source | CDE |
| Hunan Jiudian Pharmaceutical Co., Ltd | CYHS2502819 | Generic | 2025/08/05 | Not stated by source | CDE |
Loaded records: 6 filings and 3 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Tianjin Mei Hua Biopharmaceuticals Technology Co., Ltd. romanized | CYHS2602079 | Generic | 2026/08/20 | Not stated by source | CDE |
| Tianjin Mei Hua Biopharmaceuticals Technology Co., Ltd. romanized | CYHS2602078 | Generic | 2026/08/20 | Not stated by source | CDE |
| Hunan Zhuang Yuan Pharmaceutical Co., Ltd. romanized; HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2600541 | Generic | 2026/02/26 | Not stated by source | CDE |
| Hunan Zhuang Yuan Pharmaceutical Co., Ltd. romanized; HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2600540 | Generic | 2026/02/26 | Not stated by source | CDE |
| Guo Yuan Guo Yao (Guangdong) Pharmaceutical Group Co., Ltd. romanized | CYHS2600016 | Generic | 2026/01/05 | Not stated by source | CDE |
| Guo Yuan Guo Yao (Guangdong) Pharmaceutical Group Co., Ltd. romanized | CYHS2600015 | Generic | 2026/01/05 | Not stated by source | CDE |
Non-component matches: 36 companies with A status and 3 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 双氯芬酸钾 · No verified English name | Aarti Drugs Ltd | Y20240001007 | A | Salt-normalized ingredient | 2026/04/27 | CDE |
| 双氯芬酸钠 · No verified English name | Shaanxi Xi Yue Pharmaceutical (Fu Feng) Co., Ltd. romanized | Y20230000461 | A | Exact ingredient | 2025/12/05 | CDE |
| 双氯芬酸钠 · No verified English name | Hunan Hua Na Da Pharmaceutical Factory Shou Xing Drug Co., Ltd. romanized | Y20220000113 | A | Exact ingredient | 2025/09/01 | CDE |
| 双氯芬酸钠 · No verified English name | Amoli Organics (A Division of Umedica Laboratories Pvt. Ltd.) | Y20210000887 | A | Exact ingredient | 2026/04/29 | CDE |
| 双氯芬酸钠 · No verified English name | Shang Qiu Shi Long Xing Pharmaceutical Co., Ltd. romanized | Y20190021638 | A | Exact ingredient | 2025/06/06 | CDE |
| 双氯芬酸钠 · No verified English name | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Y20190021545 | A | Exact ingredient | 2026/03/31 | CDE |
| 双氯芬酸钾 · No verified English name | Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | Y20180001783 | A | Salt-normalized ingredient | 2024/03/13 | CDE |
| 双氯芬酸钾 · No verified English name | Novartis Pharma AG | Y20190009930 | A | Salt-normalized ingredient | — | CDE |
| 双氯芬酸钠 · No verified English name | Henan Sheng Lian Yi Pharmaceutical Co., Ltd. romanized | Y20190009840 | A | Exact ingredient | 2024/01/17 | CDE |
| 双氯芬酸钠 · No verified English name | Ningbo Si Mai Ke Pharmaceutical Co., Ltd. romanized | Y20190009675 | A | Exact ingredient | 2025/07/04 | CDE |
| 双氯芬酸钠 · No verified English name | Henan Dong Tai Pharmaceutical Co., Ltd. romanized | Y20190009545 | A | Exact ingredient | 2025/04/24 | CDE |
| 双氯芬酸钠 · No verified English name | Shaanxi Xi Yue Pharmaceutical Co., Ltd. romanized | Y20190008694 | A | Exact ingredient | 2025/07/23 | CDE |
| 双氯芬酸钾 · No verified English name | Liaoning Xing Hai Pharmaceutical Co., Ltd. romanized | Y20190008506 | A | Salt-normalized ingredient | 2025/04/15 | CDE |
| 双氯芬酸钠 · No verified English name | Topfond Pharmaceutical Co., Ltd. | Y20190007651 | A | Exact ingredient | 2024/05/09 | CDE |
| 双氯芬酸钠 · No verified English name | Henan Kang Da Pharmaceutical Co., Ltd. romanized | Y20190007641 | A | Exact ingredient | 2024/06/18 | CDE |
| 双氯芬酸钠 · No verified English name | Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | Y20190006619 | A | Exact ingredient | 2026/08/17 | CDE |
| 双氯芬酸钠 · No verified English name | Jilin Jin Heng Pharmaceutical Co., Ltd. romanized | Y20190006275 | A | Exact ingredient | 2026/05/09 | CDE |
| 双氯芬酸钠 · No verified English name | Hao Yi Sheng Pharma Group Co., Ltd. romanized | Y20190005988 | A | Exact ingredient | — | CDE |
| 双氯芬酸钠 · No verified English name | Qingdao Shou He Jin Hai Pharmaceutical Co., Ltd. romanized | Y20190005407 | A | Exact ingredient | 2024/01/12 | CDE |
| 双氯芬酸钠 · No verified English name | Heilongjiang Wu Su Li Jiang Pharmaceutical Co., Ltd. Ying Chun Branch romanized | Y20190005252 | A | Exact ingredient | 2024/03/07 | CDE |
| 双氯芬酸钾 · No verified English name | Xi Nan Pharma Co., Ltd. romanized | Y20190005229 | A | Salt-normalized ingredient | 2025/02/07 | CDE |
| 双氯芬酸钾 · No verified English name | Suzhou Di Wu Pharmaceutical Factory Co., Ltd. romanized | Y20190005077 | A | Salt-normalized ingredient | — | CDE |
| 双氯芬酸钠 · No verified English name | Suzhou Di Wu Pharmaceutical Factory Co., Ltd. romanized | Y20190005067 | A | Exact ingredient | — | CDE |
| 双氯芬酸钾 · No verified English name | Suzhou Hong Sen Pharma Co., Ltd. romanized | Y20190004729 | A | Salt-normalized ingredient | 2025/06/28 | CDE |
| 双氯芬酸钠 · No verified English name | Guangzhou Bai Yun Shan Ming Xing Pharmaceutical Co., Ltd. romanized | Y20190004481 | A | Exact ingredient | 2024/08/09 | CDE |
| 双氯芬酸钠 · No verified English name | Tie Ling Tian De Pharmaceutical Co., Ltd. romanized | Y20190004180 | A | Exact ingredient | 2026/01/14 | CDE |
| 双氯芬酸钠 · No verified English name | Hua Run Shuang He Pharma Co., Ltd. romanized | Y20190004125 | A | Exact ingredient | — | CDE |
| 双氯芬酸钾 · No verified English name | Chongqing Xi Nan He Cheng Pharmaceutical Co., Ltd. romanized | Y20190003309 | A | Salt-normalized ingredient | — | CDE |
| 双氯芬酸钠 · No verified English name | Wuhan Wu Yao Pharmaceutical Co., Ltd. romanized | Y20190003149 | A | Exact ingredient | 2025/06/12 | CDE |
| 双氯芬酸钾 · No verified English name | Henan Dong Tai Pharmaceutical Co., Ltd. romanized | Y20190002892 | A | Salt-normalized ingredient | 2025/04/11 | CDE |
| 双氯芬酸钠 · No verified English name | Tai Shan Shi Xin Ning Pharmaceutical Co., Ltd. romanized | Y20190002795 | A | Exact ingredient | 2026/02/28 | CDE |
| 双氯芬酸钠 · No verified English name | Jilin Sheng Si He Pharma Technology Co., Ltd. romanized | Y20190002756 | A | Exact ingredient | 2025/01/04 | CDE |
| 双氯芬酸钠 · No verified English name | Da Lian Ming Sen Pharmaceutical Co., Ltd. romanized | Y20190002722 | A | Exact ingredient | 2026/07/16 | CDE |
| 双氯芬酸钾 · No verified English name | Yang Zi Jiang Pharma Group Jiangsu Hai Ci Bio Pharma Co., Ltd. romanized | Y20190002713 | A | Salt-normalized ingredient | 2025/04/24 | CDE |
| 双氯芬酸钾 · No verified English name | Zhejiang Jin Hua Kang En Bei Biopharmaceutical Co., Ltd. romanized | Y20190002568 | A | Salt-normalized ingredient | — | CDE |
| 双氯芬酸钠 · No verified English name | Liao Yuan Shi Bai Kang Pharma Co., Ltd. romanized | Y20190002133 | A | Exact ingredient | 2025/09/24 | CDE |
| 双氯芬酸钾 · No verified English name | Shandong Ke Yuan Pharmaceutical Co., Ltd. romanized | Y20190001590 | A | Salt-normalized ingredient | 2025/01/04 | CDE |
| 双氯芬酸钠 · No verified English name | Zhejiang San Sheng Man Di Pharma Co., Ltd. romanized | Y20190001283 | A | Exact ingredient | 2024/08/16 | CDE |
| 双氯芬酸钠 · No verified English name | Aarti Drugs Limited | Y20180001563 | A | Exact ingredient | 2026/06/12 | CDE |
| 双氯芬酸钠 · No verified English name | Henan Sheng Lian Yi Pharmaceutical Co., Ltd. romanized | Y20180001546 | I | Exact ingredient | 2019/02/03 | CDE |
| 双氯芬酸钠 · No verified English name | Yong Ri Chemical Gong Ye Co., Ltd. Tai Zhong You Shi Factory romanized | Y20180000602 | I | Exact ingredient | 2018/10/15 | CDE |
| 双氯芬酸钠 · No verified English name | Henan Dong Tai Pharmaceutical Co., Ltd. romanized | Y20170002246 | I | Exact ingredient | 2019/05/17 | CDE |
| 双氯芬酸钾 · No verified English name | Novartis Pharma AG | Y20170001978 | A | Salt-normalized ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
CYHB2601687
Fact date: 2026/09/04 · Site observation date: 2026/10/22
View source ↗CYHB2601639
Fact date: 2026/08/26 · Site observation date: 2026/10/22
View source ↗CYHS2602079
Fact date: 2026/08/20 · Site observation date: 2026/10/22
View source ↗CYHS2602078
Fact date: 2026/08/20 · Site observation date: 2026/10/22
View source ↗Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
US$200
Billed every month
Sign in to subscribeUS$540
Billed every three months
US$180 per month
Sign in to subscribeUS$1,920
Billed every year
US$160 per month
Sign in to subscribeSeparate one-time purchase
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy